SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-22-021567
Filing Date
2022-08-08
Accepted
2022-08-08 09:01:54
Documents
72
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1861195
2 ex31-1.htm EX-31.1 16870
3 ex31-2.htm EX-31.2 16726
4 ex32-1.htm EX-32.1 5050
5 ex32-2.htm EX-32.2 4980
6 form10-q_001.jpg GRAPHIC 126358
7 form10-q_002.jpg GRAPHIC 46494
8 form10-q_003.jpg GRAPHIC 44142
9 form10-q_004.jpg GRAPHIC 22169
10 form10-q_005.jpg GRAPHIC 41032
11 form10-q_006.jpg GRAPHIC 94297
12 form10-q_007.jpg GRAPHIC 47595
13 form10-q_008.jpg GRAPHIC 98886
14 form10-q_009.jpg GRAPHIC 86766
  Complete submission text file 0001493152-22-021567.txt   8262144

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE lpcn-20220630.xsd EX-101.SCH 38228
16 XBRL CALCULATION FILE lpcn-20220630_cal.xml EX-101.CAL 50708
17 XBRL DEFINITION FILE lpcn-20220630_def.xml EX-101.DEF 178146
18 XBRL LABEL FILE lpcn-20220630_lab.xml EX-101.LAB 337494
19 XBRL PRESENTATION FILE lpcn-20220630_pre.xml EX-101.PRE 272758
66 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1159028
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

IRS No.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36357 | Film No.: 221142749
SIC: 2834 Pharmaceutical Preparations